Drug-resistant tuberculosis.

Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev (1995) 7.55

A rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase. Antimicrob Agents Chemother (1993) 2.39

Tuberculosis in the AIDS era. Clin Microbiol Rev (1995) 1.85

The multidrug-resistant tuberculosis challenge to public health efforts to control tuberculosis. Public Health Rep (1993) 1.70

Mycobacterium avium complex and Mycobacterium tuberculosis in patients infected with the human immunodeficiency virus. West J Med (1992) 0.77

Drug-resistant Mycobacterium tuberculosis in California, 1991 to 1992. West J Med (1995) 0.75

Ocular Tuberculosis. Microbiol Spectr (2016) 0.75

Human immunodeficiency virus infection and tuberculosis: an analysis and a course of action. Bull N Y Acad Med (1994) 0.75

An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med (1992) 18.11

Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA (1995) 15.26

The emergence of drug-resistant tuberculosis in New York City. N Engl J Med (1993) 12.71

The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol (1993) 11.70

Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med (1991) 8.98

Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients. JAMA (1992) 7.84

Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers. Ann Intern Med (1992) 7.50

Identification of mycobacteria by high-performance liquid chromatography. J Clin Microbiol (1991) 7.27

Identification of major slowly growing pathogenic mycobacteria and Mycobacterium gordonae by high-performance liquid chromatography of their mycolic acids. J Clin Microbiol (1988) 6.42

Nationwide survey of drug-resistant tuberculosis in the United States. JAMA (1994) 6.14

Current practices in mycobacteriology: results of a survey of state public health laboratories. J Clin Microbiol (1993) 5.99

Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients. JAMA (1992) 5.97

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. Am J Respir Crit Care Med (1994) 5.66

Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis (1983) 5.66

Tuberculosis in the United States. JAMA (1989) 5.12

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob Agents Chemother (1996) 5.08

Rapid drug-susceptibility testing of Mycobacterium tuberculosis. Am Rev Respir Dis (1981) 4.77

Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA (1994) 4.44

The new tuberculosis. N Engl J Med (1992) 4.37

Emergence of Buruli ulcer disease in the Daloa region of Cote d'Ivoire. Am J Trop Med Hyg (1995) 4.32

Identification of clinically significant Mycobacterium fortuitum complex isolates. J Clin Microbiol (1981) 4.24

Multidrug-resistant tuberculosis. Ann Intern Med (1992) 4.06

Mycobacterium avium-intracellulare: a cause of disseminated life-threatening infection in homosexuals and drug abusers. Ann Intern Med (1982) 3.58

Extrapulmonary tuberculosis in the United States. Am J Epidemiol (1979) 3.53

The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis (1987) 3.48

Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis (1982) 3.38

Separation of Mycobacterium bovis BCG from Mycobacterium tuberculosis and Mycobacterium bovis by using high-performance liquid chromatography of mycolic acids. J Clin Microbiol (1992) 3.36

High-performance liquid chromatography patterns of mycolic acids as criteria for identification of Mycobacterium chelonae, Mycobacterium fortuitum, and Mycobacterium smegmatis. J Clin Microbiol (1990) 3.27

Rapid radiometric methods to detect and differentiate Mycobacterium tuberculosis/M. bovis from other mycobacterial species. Am Rev Respir Dis (1984) 3.25

Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in south Florida. Ann Intern Med (1984) 3.25

Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis (1993) 3.16

Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis (1978) 3.15

Identification of Mycobacterium avium complex strains and some similar species by high-performance liquid chromatography. J Clin Microbiol (1992) 3.03

Mycobacterium celatum sp. nov. Int J Syst Bacteriol (1993) 2.97

Extrapulmonary tuberculosis in the United States. Am Rev Respir Dis (1990) 2.81

Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob Agents Chemother (1989) 2.68

Opportunistic pathogens in the genus Mycobacterium. Annu Rev Microbiol (1985) 2.67

Isolation and characterization of a unique group of slowly growing mycobacteria: description of Mycobacterium lentiflavum sp. nov. J Clin Microbiol (1996) 2.66

Tuberculosis symposium: emerging problems and promise. J Infect Dis (1993) 2.55

Tuberculosis morbidity in the United States: final data, 1990. MMWR CDC Surveill Summ (1991) 2.53

High-performance liquid chromatography of mycolic acids as a tool in the identification of Corynebacterium, Nocardia, Rhodococcus, and Mycobacterium species. J Clin Microbiol (1986) 2.51

Multidrug-resistant tuberculosis in the New York State prison system, 1990-1991. J Infect Dis (1994) 2.45

Improved method for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Clin Microbiol (1982) 2.44

Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism. J Clin Microbiol (1993) 2.40

Geographic distribution, frequency, and specimen source of Mycobacterium avium complex serotypes isolated from patients with acquired immunodeficiency syndrome. J Clin Microbiol (1990) 2.35

Risk factors for transmission of Mycobacterium tuberculosis in a primary school outbreak: lack of racial difference in susceptibility to infection. Am J Epidemiol (1994) 2.34

Fourth report of the cooperative, open-ended study of slowly growing mycobacteria by the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1991) 2.31

Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity. Antimicrob Agents Chemother (1983) 2.25

Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis. Antimicrob Agents Chemother (1979) 2.24

Epidemiology of tuberculosis in the United States. Epidemiol Rev (1989) 2.23

Mycobacterial taxonomy. Eur J Clin Microbiol Infect Dis (1994) 2.23

Outbreak of multi-drug-resistant tuberculosis in a New York State prison, 1991. Am J Epidemiol (1994) 2.20

Peritonitis due to a mycobacterium chelonei-like organism associated with intermittent chronic peritoneal dialysis. J Infect Dis (1982) 2.20

Protection of monkeys against airborne tuberculosis by aerosol vaccination with bacillus Calmette-Guerin. Am Rev Respir Dis (1973) 2.18

Preventive therapy with isoniazid. Cost-effectiveness of different durations of therapy. JAMA (1986) 2.18

Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am Rev Respir Dis (1979) 2.15

The booster phenomenon in serial tuberculin testing. Am Rev Respir Dis (1979) 2.13

Tuberculosis in the 1980s. N Engl J Med (1980) 2.09

Changing practices in mycobacteriology: a follow-up survey of state and territorial public health laboratories. J Clin Microbiol (1996) 2.06

Semantide- and chemotaxonomy-based analyses of some problematic phenotypic clusters of slowly growing mycobacteria, a cooperative study of the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol (1996) 2.02

Analysis of mycolic acid cleavage products and cellular fatty acids of Mycobacterium species by capillary gas chromatography. J Clin Microbiol (1986) 1.97

High-performance liquid chromatography analysis of mycolic acids as an aid in laboratory identification of Rhodococcus and Nocardia species. J Clin Microbiol (1987) 1.95

In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin. Am Rev Respir Dis (1982) 1.92

Differential identification of mycobacteria. I. Tests on catalase activity. Am Rev Respir Dis (1966) 1.89

The relationship between tuberculosis and silicosis. Am Rev Respir Dis (1978) 1.89

Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients. J Clin Microbiol (1992) 1.82

Rapid identification of mycolic acid patterns of mycobacteria by high-performance liquid chromatography using pattern recognition software and a Mycobacterium library. J Clin Microbiol (1994) 1.80

Bacteriophage types of Mycobacterium tuberculosis in the United States. Am Rev Respir Dis (1982) 1.76

The tuberculin skin test. Am Rev Respir Dis (1982) 1.75

Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann Intern Med (1983) 1.75

Choice of preventive treatment for isoniazid-resistant tuberculous infection. Use of decision analysis and the Delphi technique. JAMA (1980) 1.74

Foreign-born persons with tuberculosis in the United States. Am J Public Health (1981) 1.73

Effect of ethambutol on the viable cell count in Mycobacterium smegmatis. Antimicrob Agents Chemother (1977) 1.72

Chronic tenosynovitis of the hand due to Mycobacterium nonchromogenicum: use of high-performance liquid chromatography for identification of isolates. Rev Infect Dis (1992) 1.70

Successful intermittent treatment of smear-positive pulmonary tuberculosis in six months: a cooperative study in Poland. Am Rev Respir Dis (1982) 1.69

The prevalence of tuberculosis and drug resistance among Haitians. N Engl J Med (1982) 1.68

Current tuberculosis screening practices. Am J Public Health (1984) 1.67

Prevalence of nontuberculous mycobacteria in water supplies of hemodialysis centers. Appl Environ Microbiol (1988) 1.67